Share

May 04, 2021; 96 (18) Views & Reviews

National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome

Douglas I. Katz, Charles Bernick, David W. Dodick, Jesse Mez, Megan L. Mariani, Charles H. Adler, Michael L. Alosco, Laura J. Balcer, Sarah J. Banks, William B. Barr, David L. Brody, Robert C. Cantu, Kristen Dams-O'Connor, Yonas E. Geda, Barry D. Jordan, Thomas W. McAllister, Elaine R. Peskind, Ronald C. Petersen, Jennifer V. Wethe, Ross D. Zafonte, Éimear M. Foley, Debra J. Babcock, Walter J. Koroshetz, Yorghos Tripodis, Ann C. McKee, Martha E. Shenton, Jeffrey L. Cummings, Eric M. Reiman, Robert A. Stern
First published March 15, 2021, DOI: https://doi.org/10.1212/WNL.0000000000011850
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
1095

Share

Article Information

vol. 96 no. 18 848-863
DOI: 
https://doi.org/10.1212/WNL.0000000000011850
PubMed: 
33722990
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received September 1, 2020
  • Accepted in final form February 1, 2021
  • First Published March 15, 2021.

Article Versions

Copyright & Usage: 
© 2021 American Academy of Neurology

Author Disclosures

    1. Douglas I. Katz, MD,
    2. Charles Bernick, MD,
    3. David W. Dodick, MD,
    4. Jesse Mez, MD,
    5. Megan L. Mariani, BS,
    6. Charles H. Adler, MD, PhD,
    7. Michael L. Alosco, PhD,
    8. Laura J. Balcer, MD,
    9. Sarah J. Banks, PhD,
    10. William B. Barr, PhD,
    11. David L. Brody, MD, PhD,
    12. Robert C. Cantu, MD,
    13. Kristen Dams-O'Connor, PhD,
    14. Yonas E. Geda, MD,
    15. Barry D. Jordan, MD,
    16. Thomas W. McAllister, MD,
    17. Elaine R. Peskind, MD,
    18. Ronald C. Petersen, MD, PhD,
    19. Jennifer V. Wethe, PhD,
    20. Ross D. Zafonte, DO,
    21. Éimear M. Foley, MS,
    22. Debra J. Babcock, MD, PhD,
    23. Walter J. Koroshetz, MD,
    24. Yorghos Tripodis, PhD,
    25. Ann C. McKee, MD,
    26. Martha E. Shenton, PhD,
    27. Jeffrey L. Cummings, MD,
    28. Eric M. Reiman, MD and
    29. Robert A. Stern, PhD
  1. Douglas I. Katz, MD,
    2. Scientific Advisory Boards:

    1. (1) Chair, External Scientific Advisory Board, VA Rehabilitation Research and Development TBI Center of Excellence, Boston; MA (2) Data Safety Monitoring Board Multicenter Evaluation of Memory Remediation After TBI With Donepazil (MEMRI-TBI-D) NIDILRR Grant Number: H133A130047

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) travel support for talks and conferences on DoC from organizations: World Federation of Neurorehabilitation, International Brain Injury Association, Moody Foundation/ Galveston Brain Injury Conference

    Editorial Boards:

    1. (1) Journal of Head Trauma Rehabilitation, Editorial Board, 1994-present (2) Neurorehabilitation and Neural Repair, Assoc. Editor, 2002-present (3) Journal of Neurotrauma, eidtorial board, 2013- present

    Patents:

    1. NONE

    Publishing Royalties:

    1. (1) Brain Injury Medicine, Principles and Practice, Demos, 2013 (2) Lash Publications, Post-traumatic seizures, 2009

    Employment, Commercial Entity:

    1. (1)Encompass Health, (stipend) Medical Director of the Acquired Brain Injury Program at Braintree Rehab. Hosp., 2015-present

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. (1) Encompass Health Health Medical Directors’ Conference, Honorarium, Keynote address (2) Univeristy Massachusetts, Dept Neurology, Neurosurgery Grand Rounds

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) NIH (NINDS) 50202423 PI: Ann McKee MD, CTE and Posttraumatic Neurodegeneration: Neuropathology and Ex Vivo Imaging, Co-investigator, 2014-2018 (2) NIH (NINDS) 1U01NS093334-01 PI: Robert Stern PhD, Chronic Traumatic Encephalopathy: Detection, Diagnosis, Course, and Risk Factors, Co-investigator, 2016-2022 (3) NIH (NICHD) 5R21HD089088-02 PI: Rhoda Au, PhD, Impact of Traumatic Brain Injury on Brain Aging and Dementia, Co- investigator, 2016-2018

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. (1) expert testimony in several legal cases involving patients with brain injury

  2. Charles Bernick, MD,
    3. Scientific Advisory Boards:

    1. 1. Biogen Aducanumab Advisory Board

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. 1. UFC 2. Top Rank Promotions 3. Haymon Boxing

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. David W. Dodick, MD,
    4. Scientific Advisory Boards:

    1. AEON, Amgen, Ctrl M, Allergan/Abbvie, Biohaven, Lundbeck, Promius, Eli Lilly, eNeura, Novartis, Impel, Satsuma, Theranica, Nocira, Zosano, Pieris, Praxis, Revance, Equinox.

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Speaker honoraria: Eli Lilly, Novartis Canada, Amgen, Lundbeck, CME Outfitters, Curry Rockefeller Group, Global Access Meetings, KLJ Associates, Academy for Continued Healthcare Learning, Majallin LLC, Medlogix Communications, MJH Lifesciences, Miller Medical Communications, Southern Headache Society (MAHEC), WebMD Health/Medscape

    Editorial Boards:

    1. UpToDate, Lancet Neurology, Headache, Cephalalgia, Postgraduate Medicine

    Patents:

    1. Patent 8,501,195 Injection paradigm for administration of Botulinum Toxins

    Publishing Royalties:

    1. (1) Wolff's Headache 8th edition, Oxford University Press, 2009; (2) Headache. Oxford University Press, 2016. 3. Emergency Headache Diagnosis and Management, Cambridge University Press.4. Oxford Textbook on Headache, 2020

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Consulting: AEON, Amgen, Clexio, Cerecin, Cooltech, Ctrl M, Allergan, Alder, Biohaven, Linpharma, Lundbeck, Promius, Eli Lilly, eNeura, Novartis, Impel, Satsuma, Theranica, WL Gore, Nocira, XoC, Zosano, Upjohn (Division of Pfizer), Pieris, Praxis, Revance, Equinox.

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. All commercial entities: Stock Options/Shareholder/Patents/Board of Directors: Ctrl M (options), Aural analytics (options), ExSano (options), Palion (options), Healint (Options), Theranica (Options), Second Opinion/Mobile Health (Options), Epien (Options/Board), Nocira (options), Matterhorn (Shares/Board), Ontologics (Shares/Board), King-Devick Technologies (Options/Board), Precon Health (Options/Board).

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Department of Defense (PI clinical trial; 2018-2023), National Institutes of Health (Co-investigator 2018), Henry Jackson Foundation (Co-investigator 2019-2020), American Migraine Foundation (PI American Registry for Migraine Research 2015-2019), Patient Centered Outcomes Research Institute (PCORI; Medication Overuse Treatment Strategy Trial - Co-PI; 2016-2021)

    Research Support, Academic Entities:

    1. Thomas Jefferson University (education)

    Research Support, Foundations and Societies:

    1. Expense reimbursement: American Migraine Foundation, American Headache Society, American Academy of Neurology, International Headache Society, Henry Jackson Foundation, American Brain Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. Stock Options/Shareholder/Patents/Board of Directors: Ctrl M (options), Aural analytics (options), ExSano (options), Palion (options), Healint (Options), Theranica (Options), Second Opinion/Mobile Health (Options), Epien (Options/Board), Nocira (options), Matterhorn (Shares/Board), Ontologics (Shares/Board), King-Devick Technologies (Options/Board), Precon Health (Options/Board). Board of Directors: Precon Health, Epien, Matterhorn, Ontologics, King-Devick Technologies.Professional society fees or reimbursement for travel: American Academy of Neurology, American Brain Foundation, American Headache Society, American Migraine Foundation, International Headache Society, Canadian Headache Society. Stock/Stock Options, Medical Equipment & Materials: Stock Options/Shareholder/Patents/Board of Directors: Ctrl M (options), Aural analytics (options), ExSano (options), Palion (options), Healint (Options), Theranica (Options), Second Opinion/Mobile Health (Options), Epien (Options/Board), Nocira (options), Matterhorn (Shares/Board), Ontologics (Shares/Board), King-Devick Technologies (Options/Board), Precon Health (Options/Board).

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Jesse Mez, MD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Concussion Legacy Foundation: Funding for travel American Academy of Neurology: Funding for travel and speaker honoraria International Neuropsychological Society: Funding for travel

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. National Institute of Neurological Disorders and Stroke (U01NS086659, U01NS093334, R01NS078337, R56NS078337) National Institute of Aging (P30AG13846; supplement 0572063345, R01AG057902, R01AG061028, K23AG046377, R01AG1649, R21HD089088, F32NS096803) Department of Veterans Affairs (I01 CX001135, CSP 501, B6796-C) Department of Defense (W81XWH-13-2-0095, W81XWH-13-2-0064, W81XWH1810580, PRARP-13267017)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Alzheimer’s Association (NIRG-15-362697, NIRG-305779) Concussion Legacy Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Megan L. Mariani, BS,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Charles H. Adler, MD, PhD,
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Movement Disorder Society

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. (1) Parkinson's Disease and Movement Disorders, Humana Press, 2000

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Acadia, Acorda, Adamas, Amneal, Axovant, Eisai, Jazz, Lundbeck, Minerva, Neurocrine, Revance, Scion, Sunovion

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH/NINDS, 1U01NS093334-01, investigator, 2015-Present

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Michael J. Fox Foundation for Parkinson's Disease Research Stock/Stock Options, Medical Equipment & Materials: Cionic

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Michael L. Alosco, PhD,
    8. Scientific Advisory Boards:

    1. Corino Therapeutics Inc

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. International Neuropsychological Society, Honoraria American Academy of Neurology Sports Concussion Conference, Honoraria

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. Oxford Handbook of Adult Cognitive Disorders, Oxford University Press, 2019

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Corino Therapeutics Inc

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. National Institutes of Health, K23NS102399, PI, 2018-2023 NIH, U54 NS115266 (McKee PI), Project PI, 09/01/2019-08/31/2024 NIH, R01AG062348 (McKee PI), Co-I, 09/30/2018-05/31/2023 NIH, FF1AG0579902, Co-I, 2017-2022 NIH, U01NS093334, Co-I, 2015-2022 DoD, AZ170038, Co-I, 2018-2021 NIH, P30AG13846, Clinical Core Co-Director, 2018-2020 NIH, R44A063635, Co-I, 2019-2021 NCT03591757, Co-I, 2018-2019

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Alzheimer's Association Research Grant, Site PI, 2017-2021

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Laura J. Balcer, MD,
    9. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Journal of Neuro-Ophthalmology, Editor-in-Chief, 2019-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Biogen

    Research Support, Government Entities:

    1. NIH

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. Sarah J. Banks, PhD,
    10. Scientific Advisory Boards:

    1. non-profit entity

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. non profit, Boston University

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIA, PI, 2018-2024 California Department of Public Health, PI, 2019-2021

    Research Support, Academic Entities:

    1. Cleveland Clinic Foundation (employment)

    Research Support, Foundations and Societies:

    1. Alzheimer's Association

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  10. William B. Barr, PhD,
    11. Scientific Advisory Boards:

    1. Monteris Medical

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (1) Neuropsychology Review, Associate Editor, 2008- current. (2) Neuropsychology, Editorial Board, 2007-current (3) Archives of Clinical Neuropsychology, Editorial Board, 2010-Current (4) Assessment, Editorial Board, 2010-current.

    Patents:

    1. NONE

    Publishing Royalties:

    1. Barr WB & Morrison C (eds.) (2014). Handbook on the Neuropsychology of Epilepsy. New York: Springer.

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. Expert witness and consultant in civil and criminal litigation.

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH. U01NS093334. Site Neuropsychologist. 2015-22.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Finding a Cure for Epilepsy and Seizures (FACES)

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  11. David L. Brody, MD, PhD,
    12. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. 1) Consultant to Air Vice-Marshal Alastair Reid, Surgeon General of the UK Ministry of Defense regarding traumatic brain injury care for UK military service members. Payment for travel expenses

    Editorial Boards:

    1. 1) Acta Neuropathologica, editorial board, 2014-present 1) Journal of Neurotrauma, editorial board, 2013-present

    Patents:

    1. Intracranial hemorrhage detection and treatment devices for prolonged field care

    Publishing Royalties:

    1. Concussion Care Manual, Oxford University Press, 2018

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1) NIH intramural research program, PI, 2017-present 2) USUHS, PI and center director, 2017-present

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  12. Robert C. Cantu, MD,
    13. Scientific Advisory Boards:

    1. 1. Chairman Scientific Advisory Commitee, National Organizing Committee on Standard for Athletic Equipment (NOCSAE) 2. Consultant Senior Advisor NFL Head Neck and Spine Committee

    Gifts:

    1. Book Royalties Houghton Mifflin Harcourt

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  13. Kristen Dams-O'Connor, PhD,
    14. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. American Congress of Rehabilitation Medicine, honorarium International Neuropsychological Society, honorarium

    Editorial Boards:

    1. Journal of Head Trauma Rehabilitation, Editorial Board Member, 2019-present Journal of the International Neuropsychological Society, Editorial Board Member, 2019-2020

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) Consultation to a research project led by the James A. Haley Veteran's Medical Center with funding from The Department of Defense and Veterans Brain Injury Center. (2) Consultation to a research project led by Brown University with funding from the National Institutes of Health

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) NIH/NINDS, 1RF1NS115268-01, PI, 2019-2024 (2) NIH/NIA, 1R01 AG061028-01, PI, 2019-2023 (3) NIH/NINDS, R01 NS 102646-01-A1, Site PI, 2017-2022 (4) NIH/NINDS, U54 NS107201, Co-Investigator, 2018-2023 (5) NIH/NINDS, U54 NS115266, Co-Investigator, 2019-2024 (6) NIH/NINDS, U54 NS115322-01, Site PI, 2020-2024 (7) NIDILRR, 90DPTB0009-01-01, PI, 2017-2022 (8) PCORI, PCS-1604-35115, Site PI, 2017-2023 (9) Department of Defense, W81XWH-17-1-0330, PI, 2017- 2021 (10) Department of Defense, W81XWH PRARP, Co-PI, 2019- 2023 (11) Department of Defense, W81XWH-18-ERP-IDA, Co- Investigator, 2019-2023

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Research support from the Seton Brain Research Fund and the Christina Porter Head Trauma Fund

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  14. Yonas E. Geda, MD,
    15. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. International Clinical Research Center (in part funded by European Union) travel funding for annual advisory board meeting in Brno, Czech republic

    Editorial Boards:

    1. 2013 to present : Member, editorial board of International Psychogeriatrics. 2015 to present. Member, Editorial board of the Journal of Neuropsychiatry and Clinical Neuroscience

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. 1) 10% research effort (Co-I) funded by ROCHE (ended on December 31 of 2018). 2) Served as a one time advisory board member for Lundbeck in March of 2017.

    Research Support, Government Entities:

    1. National Institute on Aging/NIH R01AG057708 (Principal investigator).

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. 1-Harold Amos Medical Faculty Development Award (RWJ foundation). 2- European Union Regional Development Fund (CZ.1.05/1.1.00/02.0123)

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  15. Barry D. Jordan, MD,
    16. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  16. Thomas W. McAllister, MD,
    17. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. Textbook of Traumatic Brain Injury, 3rd Edition, 2019 American Psychiatric Publishing, Inc.

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. U.S. Department of Defense - Concussion Assessment, Research, and Education (CARE) Consortium. 2014-2019. W81XWH-14-2-0151 . PI NIH. Transforming Research and Clinical Knowledge in Traumatic Brain Injury II (TRACK-TBI II). U01 NS086090 (Manley, G - PI)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. IP00361935 (McAllister - PI) National Collegiate Athletic Association THE NCAA-DOD GRAND ALLIANCE: Concussion Assessment, Research and Education (CARE) Consortium

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  17. Elaine R. Peskind, MD,
    18. Scientific Advisory Boards:

    1. 1) Commercial Entity: Avanir Eli Lilly Takeda Merck Acadia

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. 1) Commercial entity: Acadia

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. 1) Commercial entiry: Eli Lilly

    Research Support, Government Entities:

    1. VA R&D, I01RX000521, PI, 3/1/11-2/28/19 VA R&D, I01RX001195, PI, 8/1/13-7/31/17 VA R&D, I01CX001049, PI, 1/1/14-12/31/17 NIH, P50AG005136, Clinical Core Director, 5/1/00-4/30/17

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. 1) Commercial entity: Bristol Myers Squibb

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  18. Ronald C. Petersen, MD, PhD,
    19. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. Mild Cognitive Impairment,Oxford University Press, 2003

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) Roche, (2) Biogen, (3), Eisai as consulting; (4) Genentech as DSMB

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. National Institute on Aging: U01-AG006786 (PI) (1986-present) P50-AG016574 (PI) (1990-present) U01-AG024904 (PI) (2004-present) U01 AG016976 (PI) (1989 – present) P30 AG062677 (2019 - present)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  19. Jennifer V. Wethe, PhD,
    20. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. 1) Mayo Foundation for Medical Education & Research

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  20. Ross D. Zafonte, DO,
    21. Scientific Advisory Boards:

    1. Disclosure: Dr Zafonte received royalties from 1) Oakstone for an educational CD- Physical Medicine and Rehabilitation a Comprehensive Review;2) Springer/Demos publishing for serving as co- editor of the text Brain Injury Medicine. Dr Zafonte serves on the Scientific Advisory Board of Myomo, Oxeia Biopharma, ElMINDA and Biodirection.

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Journal of Neurotrauma, Frontiers in Neurology, JAOA

    Patents:

    1. NONE

    Publishing Royalties:

    1. Brain Injury Medicine- Demos/ Springer

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIDILRR, NIH, DOD

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. FPHS

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  21. Éimear M. Foley, MS,
    22. Scientific Advisory Boards:

    1. None

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. None

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  22. Debra J. Babcock, MD, PhD,
    23. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  23. Walter J. Koroshetz, MD,
    24. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. I am employee of National Institutes of Health

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  24. Yorghos Tripodis, PhD,
    25. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Journal of Alzheimer's Disease, Associate Editor, 2018- present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1) NINDS, K23 NS102399 , Biostatistician, 2018-2023 2) NIOSH, OH011511-01 , Biostatistician, 2018-2022 3) NICHD, HD090191, SubK PI, 2017-2022 4) NIA, AG13846, Biostatistician, 2012-2020 5) NIH, AG062348, Biostatistician, 2018-2023 6) NIEHS, ES027584 , Biostatistician, 2017-2023 7) NIA, AG054156, Biostatistician, 2016-2021 8) NIA, NS093334, Biostatistician, 2015-2022 9) NIA, AG056318, Biostatistician, 2019-2023

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  25. Ann C. McKee, MD,
    26. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. The Seminar, La Cantera Resort, San Antonio, speaking honoraria Princeton University, Princeton, New Jersey, speaking honoraria University of British Columbia, Vancouver, BC, travel 13th Göttingen German Neuroscience Society, Gottingen Germany, travel British Neuroscience Association, Dublin, Ireland, travel European Congress of Sport Science, Prague, Czech Republic, travel

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1. Title: Traumatic Brain Injury and Repetitive Head Impacts: Contributions to AD, ADRD and CTE Neuropathology and Resulting Clinical Syndromes Role in Project: Ann McKee, PI Type of Grant: U54 Funding Agency: NINDS/NIA, U54-NS-115266-01 Years Funded: 09/01/2019 – 08/31/2024 Total Direct Costs: $1,250,000/yr; $10,000,000/5 yrs 2.Title: The Contribution of Age-Related Tauopathies to Alzheimer's Disease Role in Project: Ann McKee, PI (contact), John Fonda Crary, Dennis Dickson PI Funding Agency: NIA, R01AG062348 Years Funded: 09/30/2018 – 05/31/2023 Total Direct Costs: $500,000/yr 3.Title: Tau Pathology in CTE vs. Alzheimer's Disease: Microvasculopathy and Neuroinflammation Role in Project: Ann McKee, PI Type of Grant: RO1 Funding Agency: NIA, 1RF1AG057902-01 Years Funded: 9/15/2017-9/14/2022 Total Direct Costs: $500,000/ yr 4. Title: Neuropathology Core, Boston University Alzheimer’s Disease Core Center Role in Project: Director of Neuropathology Core; Co- Investigator Type of Grant: P30 Center Grant (N. Kowall, PI) P30- AG13846 Funding Agency: National Institute on Aging Years Funded: 7/1/1996-6/30/2019 Total Direct Costs: $965,065 The major goal of this project is to build a broad-based research program in Alzheimer’s disease to better understand the phenomenology and pathophysiology of Alzheimer’s disease and related dementias, and to facilitate treatment and prevention. 5. Title: CTBI: CBI Tauopathy in Mice and Human: Neurodegeneration after Repetitive Neurotrauma: Mechanisms and Biomarker Discovery Role in Project: Ann McKee, PI Type of Grant: VA Merit Award Funding Agency: Veterans Administration, U.S. Government Years Funded: 4/01/2019-03/31/2023 Total Direct Costs: $1,000,000 Program: Neuropathological alterations after Blast TBI

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Nick and Lynn Buoniconti Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  26. Martha E. Shenton, PhD,
    27. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  27. Jeffrey L. Cummings, MD,
    28. Scientific Advisory Boards:

    1. Acadia, Actinogen, Acumen, Alector, Alkahest, Alzheon, AriBio, Avanir, Axsome, Behren Therapeutics, Biogen, Cassava, Cerecin, Cerevel, Cortexyme, Cytox, EIP Pharma, Eisai, Foresight, GemVax, Genentech, Green Valley, Grifols, Janssen, Karuna, Merck, Novo Nordisk, Otsuka, ReMYND, Resverlogix, Roche, Samumed, Samus, Signant Health, Sunovion, Suven, and United Neuroscience pharmaceutical and assessment companies

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. American Journal of Geriatric Psychiatry, Editorial Board, 2020;

    Patents:

    1. NONE

    Publishing Royalties:

    1. Copyright payments for use of the Neuropsychiatric Inventory (NPI).

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Acadia, Actinogen, Acumen, Alector, Alkahest, Alzheon, AriBio, Avanir, Axsome, Behren Therapeutics, Biogen, Cassava, Cerecin, Cerevel, Cortexyme, Cytox, EIP Pharma, Eisai, Foresight, GemVax, Genentech, Green Valley, Grifols, Janssen, Karuna, Merck, Novo Nordisk, Otsuka, ReMYND, Resverlogix, Roche, Samumed, Samus, Signant Health, Sunovion, Suven, and United Neuroscience pharmaceutical and assessment companies

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIGMS grant P20GM109025; NINDS grant U01NS093334; NIA grant R01AG053798; and NIA grant P20AG068053

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. Dr. Cummings has stock options in ADAMAS, AnnovisBio, MedAvante, and BiOasis.

    License fee payments, Technology or Inventions:

    1. Payment for use of the Neuropsychiatric Inventory (NPI).

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  28. Eric M. Reiman, MD and
    29. Scientific Advisory Boards:

    1. Alkahest, Alzheon, Aural Analytics, Denali, Green Valley, and United Neuroscience Roche and Roche Diagnostics (expenses only)

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. Use of biomarker endpoints in persons at risk to evaluation Alzheimer's prevention therapies(through Banner Health)

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. See 1 above.

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Roche and Novartis/Amgen

    Research Support, Government Entities:

    1. NINDS U01 NS093334 (co-PI) NIA R01 AG069453 (co-PI) NIA R01 AG031581 (co-PI) NIA R01 AG058468 (co-PI) NIA R01 AG055444 (co-PI) NIH OT2 OD026549 (co-PI) Arizona (Arizona Alzheimer's Consortium) PI

    Research Support, Academic Entities:

    1. Banner Research, University of Arizona, Arizona State University, Translational Genomics Research Institute and Arizona Alzheimer's Consortium

    Research Support, Foundations and Societies:

    1. Banner Alzheimer's Foundation Alzheimer's Association Anonymous Foundation Flinn Foundation NOMIS Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. ALZPath

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  29. Robert A. Stern, PhD
    30. Scientific Advisory Boards:

    1. (1) Biogen(2) NCAA Student-Athlete Concussion Injury Litigation

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (1) Frontiers in Neurotrauma, Review Editor, 2010-Present (2)Journal of Alzheimer's Disease, Associate Editor, 2016- Present

    Patents:

    1. NONE

    Publishing Royalties:

    1. (1) Visual Analog Mood Scales, Psychological Assessment Resources, Inc., 1997-Present, (2) Boston Qualitative Scoring System for the Rey-Osterreith Complex Figure, Psychological Assessment Resources, Inc., 1999-Present, (3) Neuropsychological Assessment Battery, Psychological Assessment Resources, Inc., 2003- Present Present (4) The Oxford Handbook of Adult Cognitive Disorders, Oxford University Press, 2019 (5) Sports Neurology, Handbook of Clinical Neurology Volume 158, Elsevier, 2018

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1)Eisai Inc. (2)Eli Lilly

    Research Support, Government Entities:

    1. (1) NIH, U01NS093334, mPI (Contact), 2015-2022 (2) NIH,R01NS119651, PI, 2021-2026 (3) NIH, U54NS115266, Co-I, 2019-2024 (4) NIH, R01AG062624, Site PI, 2019-2024 (5) NIH, P30-AG13846, Clinical Core Director, 2004-2019 (6) NIH R01AG059424, Co-I, 2018-2023 (7) NIH R01AG062348, Co- I, 2018-2023

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) Concussion Legacy Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. King-Devick Technologies, Inc.

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Boston University CTE Center (D.I.K.), Department of Neurology, Boston University School of Medicine, Boston; Brain Injury Program (D.I.K.), Encompass Health Braintree Rehabilitation Hospital, Braintree, MA; University of Washington Memory & Brain Wellness Clinic (C.B.), Department of Neurology, University of Washington School of Medicine, Seattle; Department of Neurology (D.W.D., C.H.A.), Mayo Clinic, Scottsdale, AZ; Boston University CTE Center (J.M., M.L.A.), Boston University Alzheimer's Disease Center, Department of Neurology, Boston University School of Medicine; Boston University CTE Center (M.L.M.), Boston University School of Medicine, MA; Departments of Neurology (L.J.B.), Ophthalmology, and Population Health, New York University Grossman School of Medicine; Departments of Neurosciences and Psychiatry University of California San Diego (S.J.B.), La Jolla; Departments of Neurology and Psychiatry (W.B.B.), New York University Grossman School of Medicine; Center for Neuroscience and Regenerative Medicine (D.L.B.), Uniformed Services University of the Health Sciences, Department of Neurology, F. Edward Hebert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD; Boston University CTE Center (R.C.C.), Boston University Alzheimer's Disease Center, Departments of Neurology and Neurosurgery, Boston University School of Medicine, MA; Departments of Rehabilitation Medicine and Neurology (K.D.-O.C.), Icahn School of Medicine, Mount Sinai, New York; Department of Neurology (Y.E.G.), Barrow Neurological Institute, Phoenix, AZ; Rancho Los Amigos National Rehabilitation Center (B.D.J.), Downey, CA; Department of Neurology (B.D.J.), Keck School of Medicine of USC. Los Angeles, CA; Departments of Psychiatry and Neurology (T.W.M.), Indiana University School of Medicine, Indianapolis; Veterans Affairs Northwest Mental Illness (E.R.P.), Research, Education, and Clinical Center, VA Puget Sound Health Care System, Seattle, WA; Department of Psychiatry and Behavioral Sciences (E.R.P.), University of Washington School of Medicine, Seattle; Mayo Clinic Alzheimer's Disease Research Center (R.C.P.), Mayo Clinic, Rochester, MN; Department of Psychiatry and Psychology (J.V.W.), Mayo Clinic, Scottsdale, AZ; Department of Physical Medicine and Rehabilitation (R.D.Z.), Spaulding Rehabilitation Hospital, Massachusetts General Hospital, Brigham and Women's Hospital, Harvard Medical School, Boston; Faculty of Psychology and Neuroscience (É.M.F.), Maastricht University, the Netherlands, Department of Psychiatry, University of Cambridge, United Kingdom; National Institute of Neurological Disorders and Stroke (D.J.B.), National Institutes of Health; National Institute of Neurological Disorders and Stroke (W.J.K.), Bethesda, MD; Boston University CTE Center (Y.T.), Boston University Alzheimer's Disease Center, Boston University School of Medicine, Department of Biostatistics, Boston University School of Public Health; Boston University CTE Center (A.C.M.), Boston University Alzheimer's Disease Center, Departments of Neurology and Pathology & Laboratory Medicine, Boston University School of Medicine; VA Boston Healthcare System (A.C.M.), US Department of Veteran Affairs, MA; Psychiatry Neuroimaging Laboratory (M.E.S.), Departments of Psychiatry and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Chambers-Grundy Center for Transformative Neuroscience (J.L.C.), Department of Brain Health, University of Nevada School of Integrated Health Sciences; Cleveland Clinic Lou Ruvo Center for Brain Health (J.L.C.), Las Vegas, NV; Banner Alzheimer's Institute (E.M.R.), Arizona State University; Department of Psychiatry (E.M.R.), University of Arizona, Phoenix, AZ; and Boston University CTE Center (R.A.S.), Boston University Alzheimer's Disease Center, Departments of Neurology, Neurosurgery, and Anatomy & Neurobiology, Boston University School of Medicine, MA.
  1. Correspondence
    Dr. Stern bobstern{at}bu.edu

Article usage

Article usage: March 2021 to October 2023

AbstractFullPdfSource
Mar 202143200201Highwire
Apr 202121412151Highwire
May 20212131137140Highwire
Jun 202115186980Highwire
Jul 20215453421Highwire
Aug 20218384744Highwire
Sep 20216354728Highwire
Oct 20218745028Highwire
Nov 202110173027Highwire
Dec 20215544433Highwire
Jan 20226123629Highwire
Feb 20227533025Highwire
Mar 20228324530Highwire
Apr 20227113325Highwire
May 20226453020Highwire
Jun 20225571911Highwire
Jul 20224191612Highwire
Aug 20224902717Highwire
Sep 20225142418Highwire
Oct 20226593120Highwire
Nov 20226652418Highwire
Dec 2022507137Highwire
Jan 20235881812Highwire
Feb 20234731311Highwire
Mar 20234942413Highwire
Apr 20234942011Highwire
May 20234473015Highwire
Jun 20236381411Highwire
Jul 20235662011Highwire
Aug 2023581119Highwire
Sep 202324598Highwire
Oct 2023284189Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me

Recommended articles